Celularity Inc.: net deferred tax assets

What this measure means

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Exact concept: us-gaap:DeferredTaxAssetsNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Celularity Inc.: total assets
• Celularity Inc.: total liabilities
• Celularity Inc.: stockholders equity
• Celularity Inc.: cash and cash equivalents
• Celularity Inc.: net income or loss
• Celularity Inc.: operating cash flow
• Celularity Inc.: capital expenditure payments
• Celularity Inc.: contract revenue excluding tax
• Celularity Inc.: financing cash flow
• Celularity Inc.: investing cash flow
• Celularity Inc.: retained earnings or deficit
• Celularity Inc.: basic weighted-average shares
• Celularity Inc.: diluted weighted-average shares
• Celularity Inc.: basic earnings per share
• Celularity Inc.: diluted earnings per share
• Celularity Inc.: income tax expense or benefit
• Celularity Inc.: net property, plant and equipment
• Celularity Inc.: operating income or loss
• Celularity Inc.: current assets
• Celularity Inc.: current liabilities
• Celularity Inc.: current accounts payable
• Celularity Inc.: goodwill carrying amount
• Celularity Inc.: net finite-lived intangible assets
• Celularity Inc.: net inventory
• Celularity Inc.: gross profit
• Celularity Inc.: cost of revenue
• Celularity Inc.: selling, general and administrative expense
• Celularity Inc.: research and development expense
• Celularity Inc.: common shares outstanding
• Celularity Inc.: cash including restricted cash
• Celularity Inc.: additional paid-in capital
• Celularity Inc.: total equity including noncontrolling interests
• Celularity Inc.: operating lease right-of-use asset
• Celularity Inc.: operating lease liability
• Celularity Inc.: gross property, plant and equipment
• Celularity Inc.: accumulated depreciation on property, plant and equipment
• Celularity Inc.: net intangible assets excluding goodwill
• Celularity Inc.: other noncurrent assets
• Celularity Inc.: other noncurrent liabilities
• Celularity Inc.: accrued current liabilities
• Celularity Inc.: prepaid expenses and other current assets
• Celularity Inc.: current contract liabilities
• Celularity Inc.: net deferred tax liabilities
• Celularity Inc.: pre-tax income or loss from continuing operations
• Celularity Inc.: profit or loss including noncontrolling interests
• Celularity Inc.: comprehensive income or loss
• Celularity Inc.: net income available to common stockholders
• Celularity Inc.: depreciation expense
• Celularity Inc.: depreciation, depletion and amortization
• Celularity Inc.: amortization of intangible assets
• Celularity Inc.: nonoperating income or expense
• Celularity Inc.: current income tax expense or benefit
• Celularity Inc.: deferred income tax expense or benefit
• Celularity Inc.: interest paid, net
• Celularity Inc.: operating lease payments
• Celularity Inc.: change in accounts receivable
• Celularity Inc.: change in inventories
• Celularity Inc.: change in accounts payable

Inspect the source

Entity

Celularity Inc. / CIK 0001752828

Captured

2026-09-21T17:29:07.737Z

SEC response SHA-256

732b52ad9f2d29e719fef49cad3d40c16039c1cb3073b05f4cf01eb23c287447

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001752828.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))